Fang Yuan1,2, John R Woollard1, Kyra L Jordan1, Amir Lerman3, Lilach O Lerman1,3, Alfonso Eirin1. 1. Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA. 2. Department of Cardiology, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Henan, PR China. 3. Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
Abstract
AIMS: The mechanisms responsible for cardiac damage in the early stages of metabolic syndrome (MetS) remain unknown. Mitochondria are intimately associated with cellular myofibrils, with the cytoskeleton functioning as a linkage coordinator, and closely associated to the calcium release sites of the sarcoplasmic reticulum (SR). We hypothesized that early MetS is characterized by mitochondria-related myocardial damage, associated with altered cytoskeletal-mitochondria-SR interaction. METHODS AND RESULTS: Domestic pigs were studied after 16 weeks of diet-induced MetS, MetS treated for the last 4 weeks with the mitochondrial-targeted peptide elamipretide (ELAM; 0.1 mg/kg SC q.d), or Lean controls (n = 6/group). Cardiac remodeling and function were assessed by fast comuted tomography. Myocardial mitochondrial structure, SR-mitochondria interaction, calcium handling, cytoskeletal proteins, oxidative stress, and apoptosis were studied ex-vivo. MetS pigs developed hyperlipidemia, hypertension, and insulin resistance, yet cardiac function was preserved. MetS-induced mitochondrial disorganization, decreased (C18:2)4 cardiolipin, disrupted ATP/ADP balance, and decreased cytochrome-c oxidase (COX)-IV activity. MetS also increased mitochondrial hydrogen peroxide (H2O2) production, decreased nicotinamide adenine dinucleotide phosphate (NADPH)/NADP and GSH/GSSG, and decreased myocardial desmin and β2 tubulin immunoreactivity, and impaired SR-mitochondrial interaction and mitochondrial calcium handling, eliciting myocardial oxidative stress and apoptosis. ELAM improved mitochondrial organization and cardiolipin species profile, restored ATP/ADP ratio and COX-IV activity, decreased H202 production, and improved generation of NADPH and GSH. ELAM also improved cytoskeletal-mitochondria-SR interaction and mitochondrial calcium handling, attenuating oxidative stress, and apoptosis. CONCLUSIONS: Disorganization of cardiomyocyte cytoskeletal-mitochondria-SR network is associated with cardiac reversible changes in early MetS, preceding overt cardiac dysfunction. These findings may introduce novel therapeutic targets for blunting cardiac damage in early MetS. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: The mechanisms responsible for cardiac damage in the early stages of metabolic syndrome (MetS) remain unknown. Mitochondria are intimately associated with cellular myofibrils, with the cytoskeleton functioning as a linkage coordinator, and closely associated to the calcium release sites of the sarcoplasmic reticulum (SR). We hypothesized that early MetS is characterized by mitochondria-related myocardial damage, associated with altered cytoskeletal-mitochondria-SR interaction. METHODS AND RESULTS: Domestic pigs were studied after 16 weeks of diet-induced MetS, MetS treated for the last 4 weeks with the mitochondrial-targeted peptide elamipretide (ELAM; 0.1 mg/kg SC q.d), or Lean controls (n = 6/group). Cardiac remodeling and function were assessed by fast comuted tomography. Myocardial mitochondrial structure, SR-mitochondria interaction, calcium handling, cytoskeletal proteins, oxidative stress, and apoptosis were studied ex-vivo. MetS pigs developed hyperlipidemia, hypertension, and insulin resistance, yet cardiac function was preserved. MetS-induced mitochondrial disorganization, decreased (C18:2)4 cardiolipin, disrupted ATP/ADP balance, and decreased cytochrome-c oxidase (COX)-IV activity. MetS also increased mitochondrial hydrogen peroxide (H2O2) production, decreased nicotinamide adenine dinucleotide phosphate (NADPH)/NADP and GSH/GSSG, and decreased myocardial desmin and β2 tubulin immunoreactivity, and impaired SR-mitochondrial interaction and mitochondrial calcium handling, eliciting myocardial oxidative stress and apoptosis. ELAM improved mitochondrial organization and cardiolipin species profile, restored ATP/ADP ratio and COX-IV activity, decreased H202 production, and improved generation of NADPH and GSH. ELAM also improved cytoskeletal-mitochondria-SR interaction and mitochondrial calcium handling, attenuating oxidative stress, and apoptosis. CONCLUSIONS: Disorganization of cardiomyocyte cytoskeletal-mitochondria-SR network is associated with cardiac reversible changes in early MetS, preceding overt cardiac dysfunction. These findings may introduce novel therapeutic targets for blunting cardiac damage in early MetS. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Xin Zhang; Zi-Lun Li; John A Crane; Kyra L Jordan; Aditya S Pawar; Stephen C Textor; Amir Lerman; Lilach O Lerman Journal: Hypertension Date: 2014-04-21 Impact factor: 10.190
Authors: Zi-Lun Li; John R Woollard; Behzad Ebrahimi; John A Crane; Kyra L Jordan; Amir Lerman; Shen-Ming Wang; Lilach O Lerman Journal: Arterioscler Thromb Vasc Biol Date: 2012-03-01 Impact factor: 8.311
Authors: Natalia A Belikova; Yury A Vladimirov; Anatoly N Osipov; Alexandr A Kapralov; Vladimir A Tyurin; Maksim V Potapovich; Liana V Basova; Jim Peterson; Igor V Kurnikov; Valerian E Kagan Journal: Biochemistry Date: 2006-04-18 Impact factor: 3.162
Authors: Alfonso Eirin; Zilun Li; Xin Zhang; James D Krier; John R Woollard; Xiang-Yang Zhu; Hui Tang; Sandra M Herrmann; Amir Lerman; Stephen C Textor; Lilach O Lerman Journal: Hypertension Date: 2012-10-08 Impact factor: 10.190
Authors: Alexander V Birk; Shaoyi Liu; Yi Soong; William Mills; Pradeep Singh; J David Warren; Surya V Seshan; Joel D Pardee; Hazel H Szeto Journal: J Am Soc Nephrol Date: 2013-07-11 Impact factor: 10.121
Authors: Craig S Stump; Kevin R Short; Maureen L Bigelow; Jill M Schimke; K Sreekumaran Nair Journal: Proc Natl Acad Sci U S A Date: 2003-06-13 Impact factor: 11.205
Authors: C Fernandez-Sanz; M Ruiz-Meana; E Miro-Casas; E Nuñez; J Castellano; M Loureiro; I Barba; M Poncelas; A Rodriguez-Sinovas; J Vázquez; D Garcia-Dorado Journal: Cell Death Dis Date: 2014-12-18 Impact factor: 8.469
Authors: Arash Aghajani Nargesi; Lihong Zhang; Hui Tang; Kyra L Jordan; Ishran M Saadiq; Stephen C Textor; Lilach O Lerman; Alfonso Eirin Journal: J Hypertens Date: 2019-10 Impact factor: 4.844
Authors: Arash Aghajani Nargesi; Xiang-Yang Zhu; Ishran M Saadiq; Kyra L Jordan; Amir Lerman; Lilach O Lerman; Alfonso Eirin Journal: Am J Hypertens Date: 2020-08-04 Impact factor: 2.689
Authors: Mitchell E Allen; Edward Ross Pennington; Justin B Perry; Sahil Dadoo; Marina Makrecka-Kuka; Maija Dambrova; Fatiha Moukdar; Hetal D Patel; Xianlin Han; Grahame K Kidd; Emily K Benson; Tristan B Raisch; Steven Poelzing; David A Brown; Saame Raza Shaikh Journal: Commun Biol Date: 2020-07-17
Authors: Rahele A Farahani; Shasha Yu; Christopher M Ferguson; Xiang-Yang Zhu; Hui Tang; Kyra L Jordan; Ishran M Saadiq; Sandra M Herrmann; Alejandro R Chade; Amir Lerman; Lilach O Lerman; Alfonso Eirin Journal: J Cardiovasc Transl Res Date: 2021-07-16 Impact factor: 3.216